-- Surgery 2 Question Bank: Topic 33 - Parathyroid Disorders (33 MCQs)
-- Category: Surgery 2 (a0000002-0000-0000-0000-000000000002)
-- Topic: Parathyroid Disorders (c2000033-0000-0000-0000-000000000033)

INSERT INTO questions (topic_id, category_id, question_text, option_a, option_b, option_c, option_d, option_e, correct_option, explanation, difficulty, cognitive_level) VALUES
('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The parathyroid glands develop embryologically from:', 'First and second pharyngeal pouches', 'Third pouch (inferior) and fourth pouch (superior)', 'Thyroid tissue', 'Neural crest only', 'Foregut endoderm', 'B', 'Superior parathyroids: 4th pharyngeal pouch (dorsal wing). Inferior parathyroids: 3rd pouch (with thymus) - more variable position due to longer migration.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The normal number of parathyroid glands is:', 'Two', 'Four', 'Six', 'Eight', 'Variable with no normal', 'B', 'Typically 4 parathyroid glands (two superior, two inferior). Supernumerary glands in 13%, fewer than 4 in 3%. Size: 5x3x1mm, weight ~40mg each.', 'easy', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Parathyroid hormone (PTH) primarily acts to:', 'Lower serum calcium', 'Raise serum calcium and lower serum phosphate', 'Lower both calcium and phosphate', 'Has no effect on calcium', 'Raise both calcium and phosphate', 'B', 'PTH: increases serum Ca2+ via bone resorption, renal reabsorption, and intestinal absorption (via 1,25-vitamin D). Increases renal phosphate excretion (lowers PO4).', 'easy', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Primary hyperparathyroidism is most commonly caused by:', 'Parathyroid carcinoma', 'Single parathyroid adenoma (80-85%)', 'Four-gland hyperplasia', 'Ectopic PTH production', 'Vitamin D deficiency', 'B', 'Primary HPT causes: single adenoma (80-85%), double adenoma (2-5%), four-gland hyperplasia (10-15%), carcinoma (<1%). Adenoma most common, single gland disease.', 'easy', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Clinical features of primary hyperparathyroidism include:', 'Tetany and seizures', 'Bones, stones, moans, groans, and psychiatric overtones', 'Hypothyroid symptoms', 'Weight gain', 'Hypotension', 'B', 'Classic features: bones (osteitis fibrosa, fractures), stones (nephrolithiasis), moans (abdominal pain, constipation, peptic ulcer), groans (muscle weakness), psychiatric (depression, confusion).', 'easy', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Osteitis fibrosa cystica is caused by:', 'Vitamin D deficiency', 'Excessive PTH causing bone resorption', 'Osteoporosis', 'Pagets disease', 'Metastatic cancer', 'B', 'Osteitis fibrosa cystica: severe hyperparathyroidism. PTH causes osteoclastic resorption forming brown tumors (hemosiderin-laden fibrous tissue). Now rare due to earlier diagnosis.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Laboratory findings in primary hyperparathyroidism include:', 'Low calcium, high PTH', 'High calcium, high or inappropriately normal PTH, low phosphate', 'Low calcium, low PTH', 'Normal calcium, low PTH', 'High calcium, low PTH', 'B', 'Primary HPT: hypercalcemia with elevated or inappropriately normal PTH (should be suppressed). Hypophosphatemia, elevated 24hr urine calcium, vitamin D levels may be low/normal.', 'medium', 'analysis'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Localizing studies for parathyroid adenoma include:', 'MRI brain', 'Sestamibi scan and ultrasound', 'CT chest only', 'PET scan', 'Plain X-rays', 'B', 'Localization: Tc-99m sestamibi scan (retained in hyperfunctioning tissue), ultrasound, 4D-CT (emerging). Used for focused/minimally invasive surgery. Not for diagnosis.', 'easy', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Sestamibi scan identifies parathyroid adenomas because:', 'They have no blood supply', 'Mitochondria-rich adenoma cells retain the tracer longer', 'They are calcified', 'They produce iodine', 'They are cystic', 'B', 'Sestamibi: technetium-labeled isonitrile accumulates in mitochondria. Adenomas have abundant mitochondria. Dual-phase: thyroid washout, adenoma retained. SPECT improves localization.', 'medium', 'comprehension'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Indications for surgery in primary hyperparathyroidism include all EXCEPT:', 'Serum calcium >1 mg/dL above normal', 'Nephrolithiasis', 'Age <50 years', 'Mild hypercalcemia with no symptoms in elderly patient', 'Reduced bone mineral density', 'D', 'Surgery indications: symptomatic, Ca >1mg/dL above normal, CrCl<60, T-score <-2.5, renal stones, age <50. Asymptomatic mild disease in elderly may be observed.', 'medium', 'application'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Minimally invasive parathyroidectomy is appropriate when:', 'No localization studies done', 'Concordant localization on sestamibi and ultrasound identifying single adenoma', 'Four-gland hyperplasia suspected', 'MEN syndrome present', 'Failed previous surgery', 'B', 'Focused/MIP: requires localized single adenoma (concordant imaging). Intraoperative PTH monitoring confirms cure (>50% drop). Not for hyperplasia, MEN, reoperations.', 'medium', 'application'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Intraoperative PTH monitoring is used to:', 'Diagnose hyperparathyroidism', 'Confirm successful adenoma removal (PTH drops >50%)', 'Locate the adenoma', 'Replace preoperative imaging', 'Assess thyroid function', 'B', 'Intraoperative PTH (IOPTH): PTH half-life 3-5 minutes. Miami criterion: >50% drop from highest pre-excision level at 10 min post-excision predicts cure. Guides extent of exploration.', 'medium', 'application'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Common ectopic locations for parathyroid glands include:', 'Brain', 'Thymus (inferior), carotid sheath, intrathyroidal, mediastinum', 'Heart', 'Liver', 'Spleen', 'B', 'Ectopic sites: inferior glands more variable - thymus (most common ectopic), undescended, carotid sheath. Superior: retroesophageal, posterior mediastinum. 2% intrathyroidal.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Parathyroid carcinoma should be suspected when:', 'Mild hypercalcemia', 'Very high calcium (>14 mg/dL), palpable mass, and very high PTH', 'Normal calcium', 'Multiple gland disease', 'Young female patient', 'B', 'Parathyroid carcinoma features: markedly elevated calcium (often >14), very high PTH (often >3x normal), palpable neck mass, local invasion, recurrent laryngeal nerve palsy.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Treatment of parathyroid carcinoma involves:', 'Adenoma excision only', 'En bloc resection with ipsilateral thyroid lobectomy', 'Radioactive iodine', 'Chemotherapy', 'Observation', 'B', 'Parathyroid carcinoma: en bloc resection (parathyroid, ipsilateral thyroid lobe, involved structures). Avoid rupture. Adjuvant radiation controversial. Recurrences common.', 'medium', 'application'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Secondary hyperparathyroidism occurs in:', 'Primary parathyroid disease', 'Chronic kidney disease as response to hypocalcemia', 'Parathyroid cancer', 'MEN syndromes', 'Vitamin D toxicity', 'B', 'Secondary HPT: CKD causes phosphate retention, reduced 1,25-vitamin D, hypocalcemia â†’ compensatory PTH elevation. Renal osteodystrophy. Treatment: phosphate binders, vitamin D, calcimimetics.', 'easy', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Tertiary hyperparathyroidism refers to:', 'Primary HPT with renal stones', 'Autonomous PTH secretion after prolonged secondary HPT (post-renal transplant)', 'Three parathyroid adenomas', 'Parathyroid cancer', 'Vitamin D deficiency', 'B', 'Tertiary HPT: prolonged stimulation in CKD causes autonomous hyperfunction. Persists after renal transplant (hypercalcemia). May require subtotal parathyroidectomy.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Surgical options for secondary/tertiary HPT include:', 'Single adenoma excision', 'Subtotal parathyroidectomy or total parathyroidectomy with autotransplantation', 'Minimally invasive approach', 'Thyroidectomy', 'No surgery indicated', 'B', 'Surgery for renal HPT: subtotal (3.5 gland) or total parathyroidectomy with forearm autotransplant. All glands hyperplastic. Cryopreservation for potential re-implantation.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Hungry bone syndrome occurs after parathyroidectomy due to:', 'Blood loss', 'Rapid calcium and phosphate uptake by bone causing hypocalcemia', 'Infection', 'RLN injury', 'Thyroid hormone deficiency', 'B', 'Hungry bone syndrome: after surgery for severe HPT. Bones rapidly remineralize, causing severe hypocalcemia. Requires aggressive IV calcium replacement. May last weeks.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Hypoparathyroidism most commonly occurs as:', 'Primary autoimmune disease', 'Complication of thyroid or parathyroid surgery', 'Congenital DiGeorge syndrome', 'Radiation injury', 'Medication side effect', 'B', 'Hypoparathyroidism causes: post-surgical (thyroidectomy, parathyroidectomy) most common, autoimmune, DiGeorge syndrome (22q11 deletion), radiation, infiltrative disease.', 'easy', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Clinical features of hypoparathyroidism include:', 'Kidney stones', 'Tetany, perioral paresthesias, muscle cramps, and seizures', 'Bone pain', 'Polyuria', 'Constipation', 'B', 'Hypoparathyroidism: hypocalcemia symptoms - neuromuscular excitability (paresthesias, tetany, Chvostek sign, Trousseau sign, laryngospasm, seizures), prolonged QT, cataracts.', 'easy', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Treatment of chronic hypoparathyroidism includes:', 'High phosphate diet', 'Calcium supplements and active vitamin D (calcitriol)', 'PTH replacement only', 'Thiazide diuretics only', 'No treatment needed', 'B', 'Treatment: oral calcium (carbonate or citrate), active vitamin D (calcitriol - bypasses need for PTH). Goal: low-normal calcium. Avoid hypercalciuria. PTH replacement available but expensive.', 'medium', 'application'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'MEN1 syndrome includes hyperparathyroidism along with:', 'Medullary thyroid cancer and pheochromocytoma', 'Pituitary adenoma and pancreatic neuroendocrine tumors', 'Mucosal neuromas', 'Marfanoid habitus', 'Retinal angiomas', 'B', 'MEN1 (3 Ps): primary hyperparathyroidism (most common, 90%), pituitary adenomas, pancreatic neuroendocrine tumors (gastrinoma, insulinoma). Menin gene mutation.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Hyperparathyroidism in MEN1 is characterized by:', 'Single adenoma', 'Four-gland hyperplasia requiring subtotal parathyroidectomy', 'Parathyroid carcinoma', 'Responds to medical therapy', 'Never requires surgery', 'B', 'MEN1 HPT: multigland disease (hyperplasia), younger onset, recurrence common. Treatment: subtotal (3.5 gland) or total parathyroidectomy with autotransplant. Recurrence 50% at 10 years.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'MEN2A includes hyperparathyroidism along with:', 'Pituitary adenoma and pancreatic tumors', 'Medullary thyroid cancer and pheochromocytoma', 'Mucosal neuromas only', 'No other tumors', 'Insulinoma', 'B', 'MEN2A: medullary thyroid cancer (nearly 100%), pheochromocytoma (50%), primary hyperparathyroidism (20-30%). RET proto-oncogene mutation. Screen for pheo before thyroid surgery.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Familial hypocalciuric hypercalcemia (FHH) is distinguished from primary HPT by:', 'Very high PTH', 'Low urinary calcium excretion (Ca/Cr clearance ratio <0.01)', 'High urinary calcium', 'Severe symptoms', 'Response to surgery', 'B', 'FHH: autosomal dominant, CaSR mutation. Mild hypercalcemia, normal/slightly elevated PTH, LOW urinary calcium. Calcium/creatinine clearance ratio <0.01. Benign, no surgery needed.', 'hard', 'analysis'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The importance of distinguishing FHH from primary HPT is:', 'FHH requires surgery', 'FHH does not benefit from parathyroidectomy', 'FHH is malignant', 'Primary HPT is benign', 'There is no difference in treatment', 'B', 'FHH: lifelong benign hypercalcemia. Parathyroidectomy does not normalize calcium (reset calcium sensing). Surgery contraindicated - unnecessary and unhelpful.', 'medium', 'comprehension'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Calcimimetics (cinacalcet) work by:', 'Replacing PTH', 'Increasing calcium-sensing receptor sensitivity to suppress PTH', 'Increasing vitamin D', 'Blocking bone resorption', 'Increasing renal calcium excretion', 'B', 'Cinacalcet: allosteric activator of calcium-sensing receptor. Makes receptor more sensitive to calcium, suppressing PTH. Used in secondary HPT and when surgery contraindicated in primary HPT.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Persistent hyperparathyroidism after surgery is usually due to:', 'Inadequate medication', 'Missed adenoma or ectopic gland', 'Patient non-compliance', 'Thyroid disease', 'Renal failure', 'B', 'Persistent HPT (within 6 months): missed adenoma (wrong location, ectopic), unrecognized multigland disease. Recurrent HPT (after 6 months): new adenoma, regrowth. Reoperation after localization.', 'medium', 'knowledge'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Acute hypercalcemic crisis is treated with:', 'Observation', 'IV saline hydration, loop diuretics, bisphosphonates, and calcitonin', 'Oral calcium', 'Vitamin D', 'Thiazide diuretics', 'B', 'Hypercalcemic crisis: aggressive IV saline (4-6L/day), loop diuretics (after hydration), bisphosphonates (delayed onset), calcitonin (rapid but tachyphylaxis), dialysis if renal failure.', 'medium', 'application'),

('c2000033-0000-0000-0000-000000000033'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Parathyroid autotransplantation is performed:', 'Into the neck only', 'Into forearm muscle (brachioradialis) for easy access if recurrence', 'Into the thyroid', 'Into abdominal fat', 'Into the chest', 'B', 'Autotransplant: minced parathyroid tissue implanted into brachioradialis or sternocleidomastoid muscle. Allows easy surgical access if recurrent HPT. Confirms function by PTH gradient.', 'medium', 'knowledge');
